Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$334.63 - $382.47 $279,750 - $319,744
836 Added 21.6%
4,706 $1.8 Million
Q1 2023

May 15, 2023

BUY
$232.5 - $346.47 $899,775 - $1.34 Million
3,870 New
3,870 $1.34 Million
Q1 2022

May 13, 2022

SELL
$357.49 - $445.92 $1.25 Million - $1.56 Million
-3,504 Closed
0 $0
Q4 2021

Feb 15, 2022

SELL
$402.25 - $471.34 $2.17 Million - $2.54 Million
-5,386 Reduced 60.58%
3,504 $1.64 Million
Q3 2021

Nov 15, 2021

SELL
$363.01 - $468.47 $1 Million - $1.29 Million
-2,757 Reduced 23.67%
8,890 $3.77 Million
Q2 2021

Aug 10, 2021

SELL
$284.77 - $363.2 $1.49 Million - $1.91 Million
-5,246 Reduced 31.05%
11,647 $4.18 Million
Q1 2021

May 06, 2021

BUY
$257.29 - $307.53 $689,022 - $823,565
2,678 Added 18.84%
16,893 $4.76 Million
Q4 2020

Feb 11, 2021

BUY
$261.16 - $301.66 $3.71 Million - $4.29 Million
14,215 New
14,215 $4.03 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $25.5B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Edgestream Partners, L.P. Portfolio

Follow Edgestream Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.